Phase 2 Trial of Single-Agent Cobimetinib for Adults with Histiocytic Neoplasms

被引：2

作者：

Diamond, Eli L. ^{[1
]}

Durham, Benjamin ^{[2
]}

Dogan, Ahmet ^{[3
]}

Yabe, Mariko ^{[4
]}

Petrova-Drus, Kseniya ^{[3
]}

Rampal, Raajit K. ^{[5
]}

Ulaner, Gary ^{[6
]}

Lacouture, Mario ^{[7
]}

Rotemberg, Veronica ^{[7
]}

Covey, Anne ^{[2
]}

Brody, Lynn ^{[8
]}

Abdel-Wahab, Omar ^{[9
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY USA

[2] Mem Sloan Kettering Canc Ctr, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Hematopathol Serv, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY USA

[6] Hoag Family Canc Inst, Newport Beach, CA USA

[7] Mem Sloan Kettering Canc Ctr, Dept Med, Dermatol Serv, New York, NY USA

[8] MSKCC, New York, NY USA

[9] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-187508

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[21] Irofulven demonstrates clinical activity against metastatic hormone-refractory prostate cancer in a phase 2 single-agent trial
Senzer, N
Arsenau, J
Richards, D
Berman, B
MacDonald, JR
Smith, S
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (01): : 36 - 42
[22] Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma
Witzig, TE
Geyer, SM
Ghobrial, I
Inwards, DJ
Fonseca, R
Kurtin, P
Ansell, SM
Luyun, R
Flynn, PJ
Morton, RF
Dakhil, SR
Gross, H
Kaufmann, SH
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (23) : 5347 - 5356
[23] Phase II single-agent studies in elderly cancer patients
Monfardini, S
Lonardi, S
TUMORI, 2002, 88 (01) : S13 - S14
[24] Phase II study of single-agent nivolumab in patients with myelofibrosis
Abou Dalle, Iman
Kantarjian, Hagop
Daver, Naval
Masarova, Lucia
Pemmaraju, Naveen
Bose, Prithivaj
Garcia-Manero, Guillermo
Verstovsek, Srdan
ANNALS OF HEMATOLOGY, 2021, 100 (12) : 2957 - 2960
[25] A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients
Urmimala Bhattacharjee
Alka Khadwal
Nusrat Shafiq
Deepesh Lad
Prashant Sharma
Reena Das
Prateek Shukla
Arihant Jain
Gaurav Prakash
Pankaj Malhotra
Indian Journal of Hematology and Blood Transfusion, 2023, 39 : 266 - 275
[26] Adverse Events During Single-Agent Phase of Venetoclax Therapy
Parodi, Ginevra
Habib, Sabrina
Marks, Sasha
Lofaro, Thomas
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S358 - S358
[27] Phase I Dose Escalation of Single-Agent Vinblastine in Dogs
Bailey, D. B.
Rassnick, K. M.
Kristal, O.
Chretin, J. D.
Balkman, C. E.
JOURNAL OF VETERINARY INTERNAL MEDICINE, 2008, 22 (06): : 1397 - 1402
[28] Phase II study of single-agent nivolumab in patients with myelofibrosis
Iman Abou Dalle
Hagop Kantarjian
Naval Daver
Lucia Masarova
Naveen Pemmaraju
Prithivaj Bose
Guillermo Garcia-Manero
Srdan Verstovsek
Annals of Hematology, 2021, 100 : 2957 - 2960
[29] Single-Agent Cladribine As an Effective Therapy for Adults with Langerhans Cell Histiocytosis
Goyal, Gaurav
Hu, Marie
Abeykoon, Jithma P.
Bennani, Nora N.
Ryu, Jay H.
Shah, Mithun Vinod
Vassallo, Robert
Go, Ronald S.
BLOOD, 2019, 134
[30] Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Taal, Walter
Oosterkamp, Hendrika M.
Walenkamp, Annemiek M. E.
Dubbink, Hendrikus J.
Beerepoot, Laurens V.
Hanse, Monique C. J.
Buter, Jan
Honkoop, Aafke H.
Boerman, Dolf
de Vos, Filip Y. F.
Dinjens, Winand N. M.
Enting, Roelien H.
Taphoorn, Martin J. B.
van den Berkmortel, Franchette W. P. J.
Jansen, Rob L. H.
Brandsma, Dieta
Bromberg, Jacoline E. C.
van Heuvel, Irene
Vernhout, Rene M.
van der Holt, Bronno
van den Bent, Martin J.
LANCET ONCOLOGY, 2014, 15 (09): : 943 - 953

← 1 2 3 4 5 →